A function genomics screen showed that NFKB1 regulated the expression of S100A8 and S100A9, which are the subunits of CP secreted by macrophages and neutrophils, a critical IBD biomarker for monitoring disease severity [75–77]. Here, S100A9 is linked to inflammatory bowel disease.